7 results
10-K
2018 FY
ARVN
Arvinas Inc
26 Mar 19
Annual report
4:31pm
only the wild type protein (C-Abl), but not BCR-Abl—a mutated form of Abl implicated in chronic myelogenous leukemia.
When GNF-2 is converted … the application is made, or (2) a life-threatening, seriously debilitating or serious and chronic condition in the EU and that without incentives
DRS/A
rs5em0jkrcuqu
2 Aug 18
Draft registration statement (amended)
12:00am
DRS
2w2bjo o8
22 Jun 18
Draft registration statement
12:00am
- Prev
- 1
- Next